Investing.com - Novocure Ltd (NASDAQ: NVCR) reported fourth quarter EPS of $-0.45, $0.07 better than the analyst estimate of $-0.52. Revenue for the quarter came in at $133.78M versus the consensus estimate of $129.31M.
Novocure Ltd's stock price closed at $15.62. It is up 25.26% in the last 3 months and down -80.05% in the last 12 months.
Novocure Ltd saw 5 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Novocure Ltd's stock price’s past reactions to earnings here.
According to InvestingPro, Novocure Ltd's Financial Health score is "weak performance".
Check out Novocure Ltd's recent earnings performance, and Novocure Ltd's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar